Company Directory

Antibodies, proteins and immunoassays for life science research

Proteintech Europe is the UK and European subsidiary of Proteintech Group, a US-based manufacturer of research reagents. The company produces antibodies, recombinant proteins, nanobodies and immunoassay kits for life science research, with a catalogue covering more than 13,000 protein targets. Additional product lines include human cell-expressed cytokines and growth factors in research and GMP grades, ELISA kits, and nanobody-based affinity reagents. The Manchester site supports commercial and technical operations for UK and European markets.

AI-designed serum-free cell culture media for biomanufacturing

Multus Biotechnology is a UK developer and manufacturer of serum-free, animal-component-free cell culture media and growth media ingredients. The company combines machine learning and high-throughput robotic automation to design and optimise custom media formulations for specific cell types across cultivated meat, advanced therapy medicinal products, and broader biomanufacturing applications. Media is manufactured to food-safety standards from a certified facility in London.

Engineered bacterial protein polymers for cell culture and cultivated meat

MarraBio is a biotechnology company developing engineered Caf1-based protein polymers as xeno-free, thermostable alternatives to extracellular matrix proteins and growth factors used in mammalian cell culture. Its proprietary platform enables scalable, cost-effective production of multifunctional materials that provide cells with the signals required for growth and division. Applications span biomedical research, cell therapy manufacturing, and cultivated meat production.

Combinatorial stem cell screening platform for therapy development

Plasticell is a biotechnology company developing cell and gene therapies and enabling drug discovery through its proprietary platform. The technology uses bead-based combinatorial screening to test thousands of cell culture variable combinations in parallel, identifying optimised protocols for stem cell expansion, directed differentiation, and gene transduction. Applications span hematopoietic stem cell therapy, manufacture of blood cell types from iPSCs, and provision of rare human cells for pharmaceutical screening programmes.

Controlled-release orthobiologics for spinal fusion and bone repair

Locate Bio is a clinical-stage biotechnology company developing a portfolio of orthobiologic products for musculoskeletal surgery. Its proprietary Programmed Drug Release platform encapsulates recombinant proteins within biodegradable polymer scaffolds to enable controlled, extended-release delivery. Lead product LDGraft is an rhBMP-2 bone graft substitute in clinical trial for lumbar interbody fusion, having received FDA Breakthrough Device Designation. The pipeline also includes synthetic bone graft substitutes and antibiotic-eluting scaffolds for osteomyelitis.

Specialist reagent and custom service supplier

AMSBIO supplies research products and custom services to biological and pharmaceutical research organisations. Its product portfolio covers cell culture systems including three-dimensional culture models, glycobiology reagents, ELISA kits, lentiviral tools, and stem cell research products. The company also provides custom services in protein expression, histochemistry, peptide synthesis, and antibody design. AMSBIO operates from offices in the United Kingdom, Germany, Switzerland, and the United States.

Recombinant proteins, antibodies and reagents for drug development

ACROBiosystems is a global supplier of recombinant proteins, antibodies, kits and GMP-grade reagents supporting biopharmaceutical research and development. Products are used across the drug development continuum, from target discovery and candidate screening through to CMC development and clinical production. The company has particular strength in targeted therapies, cell and gene therapy applications, and companion diagnostics. ACROBiosystems Limited is the UK subsidiary of ACROBiosystems Group, a publicly listed Chinese biotechnology company.

Cell culture media, reagents, and instruments for life sciences

STEMCELL Technologies UK is the British subsidiary of STEMCELL Technologies Canada Inc., a privately held Canadian biotechnology company founded in 1993. The Cambridge facility serves as the company's European hub for sales, marketing, research and development, and customer training, supporting researchers across the UK, Ireland, and Scandinavia. The company's product range includes specialised cell culture media, cell isolation systems, antibodies, cytokines, instruments, and contract assay services for stem cell, immunology, oncology, and cell therapy research.

Bioactive molecule delivery technologies for cell culture and therapeutics

Cell Guidance Systems is a biotech and reagents company developing technologies for the delivery of bioactive molecules, with applications in cell biology research, drug development, and biomanufacturing. Its technology addresses protein instability in cell culture by providing sustained, localised release of growth factors. Its product portfolio includes growth factors, extracellular matrix products, extracellular vesicle research tools, and stem cell culture reagents. The company also conducts therapeutic research in collaboration with academic and industry partners.

Amniotic membrane biotherapies for ocular surface repair and regeneration

NuVision Biotherapies is a regenerative medicine company developing tissue-based biotherapies for ocular surface disease and trauma. Its proprietary processing technology manufactures dry-preserved human amniotic membrane grafts that retain the membrane's natural barrier and healing properties whilst enabling ambient storage. Products are sold into NHS ophthalmology and optometry settings, with additional applications in veterinary medicine.

High-purity animal-free growth factors and cytokines for cell culture

Qkine is a biotechnology company manufacturing recombinant growth factors and cytokines for stem cell, organoid and regenerative medicine research. Proteins are produced in E. coli using animal-free methods, with engineered variants available offering improved thermostability and extended bioactivity in culture. The portfolio also includes attachment factors and biomarkers, supporting applications in cellular agriculture, organ-on-a-chip and bioprinting. Customers include academic research institutions and biopharma companies worldwide.